114 related articles for article (PubMed ID: 18556837)
1. [Cerebral symptomatic toxoplasmosis treated by sulfadoxine/pyrimethamine treatment. About 6 patients].
Iba-Ba J; Ibouili RB; Kombila JB; Nzenze JR; Drave M; Essola L; Ivala M; Mistoul I; Kerault L; Menye B; Boguikouma JB
Therapie; 2008; 63(1):71-2. PubMed ID: 18556837
[No Abstract] [Full Text] [Related]
2. Cerebral toxoplasmosis in an AIDS patient.
Saito T; Takeuchi S; Taguchi H; Miyoshi I
Intern Med; 2003 Jan; 42(1):131. PubMed ID: 12583637
[No Abstract] [Full Text] [Related]
3. Efficacy of pyrimethamine/sulfadoxine in the prevention of toxoplasmic encephalitis relapses and Pneumocystis carinii pneumonia in HIV-infected patients.
Ruf B; Schürmann D; Bergmann F; Schüler-Maué W; Grünewald T; Gottschalk HJ; Witt H; Pohle HD
Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):325-9. PubMed ID: 8354297
[TBL] [Abstract][Full Text] [Related]
4. [Opportunistic infections in HIV-infected subjects: no wonders].
Ermak TN; Peregudova AV; Gruzdev BM
Ter Arkh; 2006; 78(11):80-1. PubMed ID: 17195535
[No Abstract] [Full Text] [Related]
5. A possible novel mechanism of opportunistic infection in systemic lupus erythematosus, based on a case of toxoplasmic encephalopathy.
Seta N; Shimizu T; Nawata M; Wada R; Mori K; Sekigawa I; Iida N; Maeda M; Hashimoto H
Rheumatology (Oxford); 2002 Sep; 41(9):1072-3. PubMed ID: 12209046
[No Abstract] [Full Text] [Related]
6. Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii pneumonia relapse and toxoplasmic encephalitis in patients with AIDS.
Schürmann D; Bergmann F; Albrecht H; Padberg J; Grünewald T; Behnsch M; Grobusch M; Vallée M; Wünsche T; Ruf B; Suttorp N
J Infect; 2001 Jan; 42(1):8-15. PubMed ID: 11243747
[TBL] [Abstract][Full Text] [Related]
7. Congenital toxoplasmosis: value of prenatal treatment with pyrimethamine-sulfadoxine combination.
Villena I; Quereux C; Pinon JM
Prenat Diagn; 1998 Jul; 18(7):754-6. PubMed ID: 9706662
[No Abstract] [Full Text] [Related]
8. Central nervous system toxoplasmosis in adult Ethiopians.
Amogne W; Teshager G; Zenebe G
Ethiop Med J; 2006 Apr; 44(2):113-20. PubMed ID: 17447372
[TBL] [Abstract][Full Text] [Related]
9. Relapse of Toxoplasma encephalitis and susceptibility to pyrimethamine: lack of evidence of treatment-induced resistance.
Caramello P; Brancale T; Forno B; Lucchini A; Pollono AM; Ullio A; Gioannini P; Viano I; Tonso E
Antimicrob Agents Chemother; 1995 Oct; 39(10):2371-2. PubMed ID: 8619602
[No Abstract] [Full Text] [Related]
10. [Congenital toxoplasmosis. Tolerability of the sulfadoxine-pyrimethamine combination. 24 cases].
Maisonneuve H; Faber C; Piens MA; Garin JP
Presse Med; 1984 Mar; 13(14):859-62. PubMed ID: 6231609
[TBL] [Abstract][Full Text] [Related]
11. Multiple intracerebral lesions in a young male.
Deepak M; Basavaprabhu A; Soundarya M
Afr Health Sci; 2015 Sep; 15(3):1045-8. PubMed ID: 26958001
[TBL] [Abstract][Full Text] [Related]
12. [Pyrimethamine and sulfadoxine as a preventive treatment for Pneumocystis carinii and Toxoplasma encephalitis].
Teira R; Virosta M; Baraia-Etxaburu J; Muñoz J; Zubero Z; Cisterna R; Santamaría JM
Enferm Infecc Microbiol Clin; 1999; 17(7):347-9. PubMed ID: 10535188
[TBL] [Abstract][Full Text] [Related]
13. Neuropsychiatric lupus?
Sillevis Smitt P; Swaak T
Ann Rheum Dis; 1998 Jan; 57(1):9-10. PubMed ID: 9536815
[No Abstract] [Full Text] [Related]
14. Post-transplant cerebral toxoplasmosis diagnosed by magnetic resonance imaging.
Picardi M; De Rosa G; Di Salle F; Pezzullo L; Raiola A; Rotoli B
Haematologica; 1998 Jun; 83(6):570-2. PubMed ID: 9676033
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial of weekly sulfadoxine/pyrimethamine vs. daily low-dose trimethoprim-sulfamethoxazole for the prophylaxis of Pneumocystis carinii pneumonia after liver transplantation.
Torre-Cisneros J; De la Mata M; Pozo JC; Serrano P; Briceño J; Solórzano G; Miño G; Pera C; Sánchez-Guijo P
Clin Infect Dis; 1999 Oct; 29(4):771-4. PubMed ID: 10589886
[TBL] [Abstract][Full Text] [Related]
16. Marked variation in pyrimethamine disposition in AIDS patients treated for cerebral toxoplasmosis.
Winstanley P; Khoo S; Szwandt S; Edwards G; Wilkins E; Tija J; Coker R; McKane W; Beeching N; Watkin S
J Antimicrob Chemother; 1995 Aug; 36(2):435-9. PubMed ID: 8522475
[TBL] [Abstract][Full Text] [Related]
17. [Primary cerebral lymphoma in a patient with HIV infection on antiretroviral treatment].
Correa-Nazco VJ; Romero-Pérez JC; Martín V; Laynez-Cerdeña P; Miguélez-Morales M; Linares-Feria M
Rev Neurol; 1999 May 1-15; 28(9):928-9. PubMed ID: 10390762
[No Abstract] [Full Text] [Related]
18. [Azithromycin combined with pyrimethamine in the treatment of neurotoxoplasmosis, in an AIDS patient].
Trotta M; Sterrantino G; Milo D; Dionisio D; Leoncini F
Minerva Med; 1997 Mar; 88(3):117-9. PubMed ID: 9148227
[TBL] [Abstract][Full Text] [Related]
19. Alternative treatment approach to cerebral toxoplasmosis in HIV/AIDS: experience from a resource-poor setting.
Goswami RP; Goswami RP; Rahman M; Ray Y; Tripathi SK
Int J STD AIDS; 2015 Oct; 26(12):864-9. PubMed ID: 25411350
[TBL] [Abstract][Full Text] [Related]
20. Treating AIDS-associated cerebral toxoplasmosis - pyrimethamine plus sulfadiazine compared with cotrimoxazole, and outcome with adjunctive glucocorticoids.
Arens J; Barnes K; Crowley N; Maartens G
S Afr Med J; 2007 Oct; 97(10):956-8. PubMed ID: 18000578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
